NL300036I1 - Liposomale formuleringen met een hoge anti-neoplastisch middel/lipideverhouding. - Google Patents

Liposomale formuleringen met een hoge anti-neoplastisch middel/lipideverhouding.

Info

Publication number
NL300036I1
NL300036I1 NL300036C NL300036C NL300036I1 NL 300036 I1 NL300036 I1 NL 300036I1 NL 300036 C NL300036 C NL 300036C NL 300036 C NL300036 C NL 300036C NL 300036 I1 NL300036 I1 NL 300036I1
Authority
NL
Netherlands
Prior art keywords
drug
liposomes
lipid ratio
neoplastic
high anti
Prior art date
Application number
NL300036C
Other languages
English (en)
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21808094&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300036(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of NL300036I1 publication Critical patent/NL300036I1/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NL300036C 1987-03-05 2001-01-15 Liposomale formuleringen met een hoge anti-neoplastisch middel/lipideverhouding. NL300036I1 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2215487A 1987-03-05 1987-03-05

Publications (1)

Publication Number Publication Date
NL300036I1 true NL300036I1 (nl) 2001-03-01

Family

ID=21808094

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300036C NL300036I1 (nl) 1987-03-05 2001-01-15 Liposomale formuleringen met een hoge anti-neoplastisch middel/lipideverhouding.

Country Status (17)

Country Link
EP (2) EP0290296B1 (nl)
JP (1) JP2882607B2 (nl)
KR (1) KR960013703B1 (nl)
AT (2) ATE231389T1 (nl)
AU (3) AU620545B2 (nl)
BR (1) BR1100687A (nl)
CA (1) CA1338702C (nl)
DE (3) DE3856550T2 (nl)
DK (1) DK174869B1 (nl)
ES (2) ES2198429T3 (nl)
GR (1) GR3020725T3 (nl)
HK (1) HK1007500A1 (nl)
IE (1) IE75713B1 (nl)
IL (1) IL85608A (nl)
LU (1) LU90717I2 (nl)
NL (1) NL300036I1 (nl)
WO (1) WO1988006442A1 (nl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1323306C (en) * 1987-03-05 1993-10-19 Mircea C. Popescu Pharmacological agent-lipid solution preparation
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
IE63518B1 (en) * 1987-11-18 1995-05-03 Vestar Inc Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
EP0472639A4 (en) * 1989-05-15 1992-07-01 The Liposome Company, Inc. Accumulation of drugs into liposomes by a proton gradient
US5227170A (en) * 1989-06-22 1993-07-13 Vestar, Inc. Encapsulation process
EP0412507A1 (de) * 1989-08-08 1991-02-13 Humboldt-Universität zu Berlin Verfahren zur Grössenfraktionierung hochmolekularer Stoffe mit Hilfe von Hohlträgern
ATE138803T1 (de) * 1990-07-31 1996-06-15 Liposome Co Inc Anhäufung von aminosäuren und peptiden in liposomen
WO1992004009A1 (en) * 1990-09-10 1992-03-19 School Of Pharmacy, University Of London Liposomes
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
EP0661044A1 (en) * 1991-07-03 1995-07-05 NeXstar Pharmaceuticals, Inc. Drug-containing liposomes
EP0546951A1 (en) * 1991-12-13 1993-06-16 The Liposome Company, Inc. Combination of liposome encapsulated antineoplastic agents, such as doxorubicin with colony stimulating factors
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5741516A (en) * 1994-06-20 1998-04-21 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
DE4430592A1 (de) 1994-08-20 1996-02-22 Max Delbrueck Centrum Liposomale Zubereitung, ihre Herstellung und ihre Verwendung
US5858397A (en) * 1995-10-11 1999-01-12 University Of British Columbia Liposomal formulations of mitoxantrone
DE19639811A1 (de) * 1996-09-27 1998-04-02 Artur Herzog Dr Mesmer Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
WO1998016199A1 (en) * 1996-10-15 1998-04-23 The Liposome Company, Inc. N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
DE69928805T2 (de) * 1998-06-18 2006-08-31 Hassan, Moustapha, Dr. Liposomale Formulierungen von Busulfan
US7351427B2 (en) 1998-06-18 2008-04-01 Busulipo Ab Pharmaceutical composition, a method of preparing it and a method of treatment by use thereof
JP2003513030A (ja) * 1999-11-05 2003-04-08 シード・キャピタル・インヴェストメンツ−２・（エスシーアイ−２）・ベスローテン・フエンノートシャップ 低い水溶性および脂肪親和性を示す物質のカプセル化方法、およびこの方法により得られる製剤
US20030124180A1 (en) * 2000-05-02 2003-07-03 Jurgen Ebert Liposomes containing active substances
ES2332584T3 (es) * 2001-03-27 2010-02-09 Phares Pharmaceutical Research N.V. Metodo y composicion para solubilizar un compuesto biologicamente activo con baja solubilidad en agua.
WO2003032947A2 (en) * 2001-09-06 2003-04-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem A method for preparing liposome formulations with a predefined release profile
US9186322B2 (en) 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
MXPA05001312A (es) * 2002-08-02 2005-08-03 Transave Inc Agregados de platino y proceso para producir los mismos.
WO2004047802A2 (en) * 2002-11-26 2004-06-10 Gilead Sciences, Inc. Liposomal formulations
ATE453381T1 (de) * 2002-12-31 2010-01-15 Bharat Serums & Vaccines Ltd Nicht-pegylierte lang-zirkulierende liposome
WO2005072776A2 (en) * 2004-01-30 2005-08-11 Instytut Farmaceutyczny Liposomal formulations of the antineoplastic agents
JP4833836B2 (ja) 2004-03-26 2011-12-07 テルモ株式会社 リポソーム製剤
WO2006012502A2 (en) * 2004-07-23 2006-02-02 Rigel Pharmaceuticals, Inc. Formulation of insoluble small molecule therapeutics in lipid-based carriers
EP1847315A4 (en) * 2005-01-18 2013-04-17 Univ Hokkaido Nat Univ Corp METHOD FOR COATING PARTICLES WITH LIPID FILM
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
CA2631875A1 (en) 2005-12-06 2007-10-04 Rigel Pharmaceuticals, Inc. Formulation of insoluble small molecule therapeutics in lipid-based carriers
US20110244028A1 (en) * 2008-09-26 2011-10-06 Steve Leigh Method of solubilizing biologically active compounds
CN101474155B (zh) * 2009-01-24 2011-03-16 重庆医科大学 注射用肺靶向载药前体脂质体及其使用方法
PL387296A1 (pl) * 2009-02-17 2010-08-30 Instytut Farmaceutyczny Sposób aktywnego zamykania amfifilowych substancji czynnych w strukturach liposomowych
EP2440176A2 (en) * 2009-06-08 2012-04-18 Epitarget AS Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
PL226015B1 (pl) 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
WO2014039533A2 (en) 2012-09-04 2014-03-13 Eleison Pharmaceuticals, Llc Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
EP3470061A1 (en) 2012-11-20 2019-04-17 Spectrum Pharmaceuticals, Inc. Improved method for the preparation of a dosage of liposome encapsulated vincristine for therapeutic use
TWI678213B (zh) 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物
BR112019014718A2 (pt) 2017-01-18 2020-03-10 Temasek Life Sciences Laboratory Limited Lipossomas hiperestabilizados aumentam o direcio-namento de células mitóticas
GR20180100082A (el) * 2018-02-28 2019-09-25 ΝΙΚΟΛΑΟΣ Α. ΦΙΚΙΩΡΗΣ ΚΑΙ ΣΙΑ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΗΝΗΣ με δ.τ. IN TOUCH HEALTH Ε.Π.Ε Μεθοδος για την παραγωγη οχηματων μεταφορας λιπιδιων
WO2021076630A1 (en) * 2019-10-14 2021-04-22 The Regents Of The University Of California Nano-enabled immunotherapy in cancer
CN112023059B (zh) * 2020-06-03 2023-03-24 太原师范学院 一种pH响应型阿霉素无载体纳米药物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
US4551288A (en) * 1982-08-16 1985-11-05 Sandoz, Inc. Processes for the preparation of liposome drug delivery systems
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
CA1264668C (en) * 1984-06-20 1990-01-23 EXTRUSION TECHNIQUES FOR THE PRODUCTION OF LIPOSOMES
CA1270198C (en) * 1984-08-08 1990-06-12 Marcel B Bally ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
US4622188A (en) * 1984-12-21 1986-11-11 E. I. Du Pont De Nemours And Company Method for manufacturing liposomes
US4737323A (en) * 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents

Also Published As

Publication number Publication date
AU635435B2 (en) 1993-03-18
EP0719546B1 (en) 2003-01-22
ES2088385T3 (es) 1996-08-16
BR1100687A (pt) 2000-02-08
DK98189D0 (da) 1989-03-01
GR3020725T3 (en) 1996-11-30
DK98189A (da) 1989-03-01
DE3855265D1 (de) 1996-06-13
DE10199004I1 (de) 2001-03-29
IE960340L (en) 1988-09-05
HK1007500A1 (en) 1999-04-16
EP0290296B1 (en) 1996-05-08
ATE137670T1 (de) 1996-05-15
JP2882607B2 (ja) 1999-04-12
AU8141891A (en) 1991-10-10
IE880599L (en) 1988-09-05
DE3856550D1 (de) 2003-02-27
KR960013703B1 (ko) 1996-10-10
AU645332B2 (en) 1994-01-13
DE3856550T2 (de) 2003-12-11
AU8141791A (en) 1991-11-07
AU620545B2 (en) 1992-02-20
ES2198429T3 (es) 2004-02-01
DE3855265T2 (de) 1996-12-12
EP0719546A1 (en) 1996-07-03
LU90717I2 (fr) 2001-03-15
EP0290296A2 (en) 1988-11-09
WO1988006442A1 (en) 1988-09-07
JPH02502458A (ja) 1990-08-09
AU1481688A (en) 1988-09-26
DK174869B1 (da) 2004-01-12
CA1338702C (en) 1996-11-12
EP0290296A3 (en) 1989-06-28
IL85608A0 (en) 1988-08-31
IL85608A (en) 1992-07-15
KR890700340A (ko) 1989-04-24
IE75713B1 (en) 1997-09-24
ATE231389T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
NL300036I1 (nl) Liposomale formuleringen met een hoge anti-neoplastisch middel/lipideverhouding.
DK86988A (da) Liposompraeparat og anvendelse deraf
AU587232B2 (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles and methods for using same for tumor therapy
FI895554A0 (fi) Menetelmä liposomaalisen prostaglandiinivalmisteen valmistamiseksi
ES8607906A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares
NO873492D0 (no) Fremgangsmaate for fremstilling av antifungale preparater.
ES2013129A6 (es) Procedimiento de obtencion de una composicion farmaceutica a base de n-metil-n- (1-fenil -2- propil) -2- propinilamina.
GR1000074B (el) Λιποειδη σφαιριδια (κυστιδια) για ενδοπεριτονειακη χορηγηση θεραπευτικων παραγοντων.
DK0560138T3 (da) Liposomale præparater af virksomt stof og fremgangsmåde til deres fremstilling
GR3021231T3 (en) Process for preparing stable hydrophilic or ambiphic cream preparations containing vesicular composnents and their use